Mr. Mair is Associate at the Center for Biosecurity of UPMC. He is a public health professional by training and has extensive hands-on laboratory experience. Mr. Mair’s research focuses on public health preparedness and on improving the supply of medicines, vaccines, and other medical countermeasures needed to deal with biosecurity threats—including pandemic influenza. He is an associate editor of Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, and he is Editor of the Highlights & Happenings section of the journal. From 2001 to 2004, Mr. Mair developed and produced the Biosecurity News Update, a daily web-based briefing on biodefense news and information that is derived from open-source material. The update is disseminated to leaders in biosecurity from the academic, nonprofit, and government sectors. In 2005 when the Biosecurity News Update was reissued as the weekly Biosecurity Briefing, Mr. Mair oversaw the transition and subsequently served as Managing Editor from 2005 to 2006. Mr. Mair has worked on numerous projects related to biosecurity and has authored several articles on issues related to biosecurity. Prior to helping establish the Center for Biosecurity of UPMC in 2003, Mr. Mair was Senior Research Analyst at the Center for Civilian Biodefense Strategies at the Johns Hopkins Bloomberg School of Public Health from 2001 to 2003. In June 2001, Mr. Mair was a co-designer/controller of the Dark Winter bioterrorism exercise, and, as part of his role with the Center, he has served as a consultant to the Baltimore City Health Department on bioterrorism preparedness issues. From 1998 to 2001, Mr. Mair worked at the National Cancer Institute at the National Institutes of Health, where he conducted breast cancer research focusing on metastasis suppression. Prior to that, he spent 8 years as an infectious disease researcher at Temple University, Cooper Hospital/University Medical Center, and Coriell Institute for Medical Research where he focused on molecular epidemiology, pathogen detection, and antimicrobial resistance characterization. Mr. Mair received a BS in Molecular Biology from Juniata College and an MPH and a Certificate in Vaccine Science and Policy from the Johns Hopkins Bloomberg School of Public Health. He is a member of the Delta Omega, Alpha Chapter–National Public Health Honorary Society. | 
